18 February 2026: Researchers from RCSI University of Medicine and Health Sciences have developed a novel implant that delivers tiny growth-promoting particles directly to injured nerve cells, helping them to regrow after spinal cord injury.
The study, published in the journal Bioactive Materials , shows how a 3D implant designed to mimic the structure and stiffness of the spinal cord can be combined with tiny particles engineered to carry RNA to encourage nerve cells (neurons) to grow. The work was led by researchers at RCSI’s Tissue Engineering Research Group (TERG) and the Research Ireland Centre for Advanced Materials and BioEngineering Research (AMBER).
Spinal cord injuries often result in permanent paralysis because damaged neurons in the central nervous system have a very limited capacity to regrow. While biomaterial implants can provide physical support at the injury site, these cells also face molecular barriers that prevent their regrowth.
To overcome this, the team developed a multifunctional implant that not only supports regenerating tissue but also delivers RNA-based signals that encourage neurons to switch their growth mechanisms back on.
These signals target one such barrier, a gene called PTEN, which is known to suppress neuron regrowth after injury. By silencing PTEN at the injury site, the implant helps remove an internal barrier to repair in these cells.
“We’ve created an environment that both physically and biologically re-enhances the regenerative capacity of injured neurons, which is a key requirement for restoring function after spinal cord injury,” said Professor Fergal O’Brien, Deputy Vice Chancellor for Research and Innovation, Professor of Bioengineering and Regenerative Medicine and Head of RCSI TERG.
“In laboratory models of spinal cord injury, neurons exposed to the RNA-activated implant showed significantly enhanced growth.”
The research was developed with guidance from an advisory panel supported by the Irish Rugby Football Union Charitable Trust (IRFU-CT), bringing together people living with spinal cord injury, clinicians, neuroscientists and engineers to shape research priorities and ensure relevance to patients’ real-world needs.
“While this study focused on laboratory models, the next steps will to be to test the approach in vivo and explore how RNA-activated biomaterials could help bridge damaged spinal cord tissue and restore lost connections,” said Dr Tara McGuire who carried out the research as a PhD student in TERG.
The study was supported by the IRFU-CT and Research Ireland with additional funding from the Anatomical Society and the Health Research Board.
ENDS
For further information:
Laura Anderson, Senior Communications Officer, RCSI
087 199 0399/ lauraanderson@rcsi.ie
About RCSI University of Medicine and Health Sciences
RCSI University of Medicine and Health Sciences is ranked first in the world for its contribution to UN Sustainable Development Goal 3, Good Health and Well-being, in the Times Higher Education (THE) University Impact Rankings 2025.
Founded in 1784 as the Royal College of Surgeons in Ireland with responsibility for training surgeons in Ireland, today RCSI is an innovative, not-for-profit, international university exclusively focused on driving improvements in human health worldwide through education, research and engagement.
RCSI is among the top 300 universities worldwide in the World University Rankings (2025) and has been awarded Athena Swan Bronze accreditation for positive gender practice in higher education.
Humanarium , RCSI's public engagement space, dedicated to health and well-being, is now open at 118 St Stephen's Green in Dublin city centre. The space is designed to engage the public in dialogue about living longer, healthier and happier lives through dynamic events and exhibitions. Our aim is to bridge the gap between health sciences research, professional expertise, and public understanding, empowering people to make informed decisions about their health.
Visit the RCSI MyHealth Expert Directory to find the details of our experts across a range of healthcare issues and concerns. Recognising their responsibility to share their knowledge and discoveries to empower people with information that leads them to better health, these clinicians and researchers are willing to engage with the media in their area of expertise.
Bioactive Materials
10.1016/j.bioactmat.2026.01.022
Development of a PTEN-siRNA activated scaffold to promote axonal regrowth following spinal cord injury